Sylvia Mcbrinn
Director/Board Member presso BIOATLA, INC.
Patrimonio netto: 52 030 $ in data 31/03/2024
Profilo
Propel Bio Partners Senior Advisor Sylvia McBrinn is also a strategic Board Director, CEO, and commercialization expert with 30+ years of leadership experience in the biopharmaceutical industry.
With a strong commercial background in US and global markets, she has led successful launches of specialty to blockbuster products and grown market share for companies including Pfizer and Vernalis.
She provides biopharmaceutical companies critical insights from a career of executive governance, operational, and commercial success across a wide range of therapeutic areas including neurology, inflammation and rheumatology, pain, infectious disease/microbiome, and urology.
Currently, she serves and advises BioAtla (Nasdaq: BCAB) as Board Director, Compensation Committee Chair, and Audit Committee member, and as a Board Director of Ilya Pharma (private).
Until recently, she led as Board Director/founding CEO of early-stage biotech company Axerion Therapeutics (now ReNetX Bio), and also built and led the US subsidiary of a British biotech, Vernalis, with full P&L oversight.
Earlier, she was an EVP and GM of Andrx with full P&L responsibility, overseeing branded products with 400 employees across key business functions.
Throughout her career and board roles, she has earned a reputation of a strategic thinker with the ability to connect the dots and ask insightful questions between business direction, portfolio strategy, R&D, marketing, and commercialization.
As Global VP of Marketing at Pfizer, Ms. McBrinn led the launch and commercialization of the blockbuster product Bextra—the #1 Product launch in the US that year—achieving $1B in sales in the first 12 months and exceeding forecast by 35%.
Additionally, she built the #1 Parkinson’s disease product franchise globally, exceeding forecast by 40%.
At Vernalis, she in-licensed and relaunched Apokyn, an injectable Parkinson’s product that increased sales 42% YOY.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOATLA, INC.
0.03% | 26/12/2023 | 15 125 ( 0.03% ) | 52 030 $ | 31/03/2024 |
Posizioni attive di Sylvia Mcbrinn
| Società | Posizione | Inizio |
|---|---|---|
| BIOATLA, INC. | Director/Board Member | 15/06/2021 |
Springboard Enterprises, Inc.
 Springboard Enterprises, Inc. Internet Software/ServicesTechnology Services Springboard Enterprises, Inc. is a leading network of industry experts, investors, and innovators dedicated to building companies at scale led by women who are transforming industries in technology, life sciences, and healthcare. The non-profit company is based in Washington and has subsidiaries in the United States. Since 2000, over 890+ Springboard portfolio companies seeking investment and human capital for product development and expansion have created over $39.10b in value. With 225 exits to strategic acquirers, 27 IPOs, and 10 unicorns, Springboard entrepreneurs are transforming industries. The American company's mission is to accelerate the growth of women-led entrepreneurial companies through access to essential resources and a community of experts. Springboard is a network of entrepreneurs, investors, and advisors accelerating the success of women entrepreneurs in technology and life sciences. The company was founded by Kay Koplovitz, Amy Millman. Natalie Buford-Young has been the CEO of the company since 2020. | Corporate Officer/Principal | - |
Propel Bio Partners LLC
 Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | Consultant / Advisor | 01/03/2022 |
Precedenti posizioni note di Sylvia Mcbrinn
| Società | Posizione | Fine |
|---|---|---|
Ilya Pharma AB
 Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Director/Board Member | 01/06/2023 |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Founder | 01/01/2012 |
| Vernalis Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/12/2008 |
Andrx Laboratories, Inc.
 Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Andrx Laboratories, Inc. was a specialty pharmaceuticals company that was acquired by Watson Pharmaceuticals in November 2006. It engaged in the development and commercialization of controlled-release branded pharmaceuticals and generics. The company was founded in 1995 and was headquartered in Fort Lauderdale, FL. | Corporate Officer/Principal | 01/01/2004 |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
Formazione di Sylvia Mcbrinn
| DeSales University | Undergraduate Degree |
| Widener University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOATLA, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
Andrx Corp.
 Andrx Corp. Pharmaceuticals: MajorHealth Technology Andrx Corp. developed, manufactured, and marketed oral pharmaceutical products. The company was founded in August, 1992 and was headquartered in Davie, FL. | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Springboard Enterprises, Inc.
Springboard Enterprises, Inc. Internet Software/ServicesTechnology Services Springboard Enterprises, Inc. is a leading network of industry experts, investors, and innovators dedicated to building companies at scale led by women who are transforming industries in technology, life sciences, and healthcare. The non-profit company is based in Washington and has subsidiaries in the United States. Since 2000, over 890+ Springboard portfolio companies seeking investment and human capital for product development and expansion have created over $39.10b in value. With 225 exits to strategic acquirers, 27 IPOs, and 10 unicorns, Springboard entrepreneurs are transforming industries. The American company's mission is to accelerate the growth of women-led entrepreneurial companies through access to essential resources and a community of experts. Springboard is a network of entrepreneurs, investors, and advisors accelerating the success of women entrepreneurs in technology and life sciences. The company was founded by Kay Koplovitz, Amy Millman. Natalie Buford-Young has been the CEO of the company since 2020. | Technology Services |
Andrx Laboratories, Inc.
Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Andrx Laboratories, Inc. was a specialty pharmaceuticals company that was acquired by Watson Pharmaceuticals in November 2006. It engaged in the development and commercialization of controlled-release branded pharmaceuticals and generics. The company was founded in 1995 and was headquartered in Fort Lauderdale, FL. | Health Technology |
| Vernalis Pharmaceuticals, Inc. | |
Ilya Pharma AB
Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Health Technology |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | Finance |
- Borsa valori
- Insiders
- Sylvia Mcbrinn
